References
- Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956; 9: 53–75. doi: 10.1002/1097-0142(195601/02)9:1<;53::aid-cncr2820090104>3.0.co;2-u
- Jiang L, Huang Y, Tang Q, Zhao Q, Li Y, Wu X, et al. 18F-FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma. Oncol Lett 2018; 16: 660–5. doi: 10.3892/ol.2018.8660
- Hung JH, Hsueh C, Liao CY, Ho SY, Huang YC. Pulmonary hilar tumor: an unusual presentation of sclerosing hemangioma. Case Rep Med 2016; 16: 1–6. doi: 10.1155/2016/8919012
- Lei Y, Yong D, Jun-Zhong R, Zhi Y, Zi-Tong W. Treatment of 28 patients with sclerosing hemangioma (SH) of the lung. J Cardiothorac Surg 2012; 7: 34. doi: 10.1186/1749-8090-7-34
- Jungraithmayr W, Eggeling S, Ludwig C, Kayser G, Passlick B. Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann Thorac Cardiovasc Surg 2006; 12: 352–4. PMID: 17095978
- Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV. Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med 2003; 127: 321–5. doi: 10.5858/2003-127-0321-PSHWLN
- Wei S, Tian J, Song X, Chen Y. Recurrence of pulmonary sclerosing hemangioma. Thorac Cardiovasc Surg 2008; 56: 120–2. doi: 10.1055/s-2007-989280
- Yang CH, Lee LY. Pulmonary sclerosing pneumocytoma remains a diagnostic challenge using frozen sections: a clinicopathological analysis of 59 cases. Histopathology 2018; 72: 500–8. doi: 10.1111/his.13391
- Folescu R, Levai CM, Grigoraş ML, Arghirescu TS, Talpoş IC, Gîndac CM, et al. Expression and significance of Ki-67 in lung cancer. Rom J Morphol Embryol 2018; 59: 227–33. PMID: 29940632
- Martin B, Paesmans M, Mascaux C, Berghmans T, Lothaire P, Meert AP, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 2004; 91: 2018–25. doi: 10.1038/sj.bjc.6602233
- Jakobsen JN, Sørensen JB. Clinical impact of Ki-67 labeling index in non-small cell lung cancer. Lung Cancer 2013; 79: 1–7. doi: 10.1016/j.lung-can.2012.10.008
- Lim JH, Lee N, Choi DW, Oh HJ, Park HY, Kim KH, et al. Pulmonary sclerosing pneumocytoma mimicking lung cancer: case report and review of the literature. Thorac Cancer 2016; 7: 508–11. doi: 10.1111/1759-7714.12341
- Zhu J. Analysis of the clinical differentiation of pulmonary sclerosing pneumocytoma and lung cancer. J Thorac Dis 2017; 9: 2974–81. doi: 10.21037/jtd.2017.08.07
- Lee E, Park CM, Kang KW, Goo JM, Kim MA, Paeng JC, et al. 18F-FDG PET/CT features of pulmonary sclerosing hemangioma. Acta Radiologica 2013; 54: 24–9. doi: 10.1258/ar.2011.110474
- Nakatani Y, Inayama Y, Kamijo S, Ogawa N. Sclerosing lung hemagioma. Am J Surg Pathol 1999; 23: 240–1. doi: 10.1097/00000478-199902000-00019
- Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10: 1243–60. doi: 10.1097/JTO.0000000000000630
- Soo IX, Sittampalam K, Lim CH. Pulmonary sclerosing pneumocytoma with mediastinal lymph node metastasis. Asian Cardiovasc Thorac Ann 2017; 25: 547–9. doi: 10.1177/0218492317727668
- Iyoda A, Hiroshima K, Shiba M, Haga Y, Moriya Y, Sekine Y, et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann Thorac Surg 2004; 78: 1928–31. doi: 10.1016/j.athoracsur.2004.05.069
- Sobecki M, Mrouj K, Colinge J, Gerbe F, Jay P, Krasinska L, et al. Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res 2017; 77: 2722–34. doi: 10.1158/0008-5472.CAN-16-0707
- Rivera E, Gesthalter Y, VanderLaan P, Parikh MS. Pulmonary sclerosing pneumocytoma. J Bronchology Interv Pulmonol 2018; 25: 54–6. doi: 10.1097/LBR.0000000000000508
- Seigneurin D, Guillaud P. [Ki-67 antigen, a cell cycle and tumor growth marker]. [French]. Pathol Biol 1991; 39: 1020–8. PMID: 1666669
- Swensen SJ, Viggiano RW, Midthun DE, Müller NL, Sherrick A, Yamashita K, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214: 73–80. doi: 10.1148/radiology.214.1.r00ja1473
- Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging 2013; 13: 140–9. doi: 10.1102/1470-7330.2013.0015
- Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon OJ, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004; 233: 191–9. doi: 10.1148/radiol.2331031535
- Neuman J, Rosioreanu A, Schuss A, Turi G, Yung E, Trow TK, et al. Radiology-pathology conference: sclerosing hemangioma of the lung. Clin Imaging 2006; 30: 409–12. doi: 10.1016/j.clinimag.2006.05.030
- Xu G, Wang Z, Xiong Z, Li M, Luo W, Xu Y, et al. Correlation between pulmonary sclerosing pneumocytoma features and MSCT imaging manifestations in 34 patients: implications for precision medicine. Front Med 2021; 8: 650996. doi: 10.3389/fmed.2021.650996
- Cheung YC, Ng SH, Chang JW, Tan CF, Huang SF, Yu CT. Histopathological and CT features of pulmonary sclerosing haemangiomas. Clin Radiol 2003; 58: 630–5. doi: 10.1016/s0009-9260(03)00177-6
- Chung MJ, Lee KS, Han J, Sung YM, Chong S, Kwon OJ. Pulmonary sclerosing hemangioma presenting as solitary pulmonary nodule: dynamic CT findings and histopathologic comparisons. Am J Roentgenol 2006; 187: 430–7. doi: 10.2214/AJR.05.0460
- Wang QB, Chen YQ, Shen JJ, Zhang C, Song B, Zhu XJ, et al. Sixteen cases of pulmonary sclerosing haemangioma: CT findings are not definitive for preoperative diagnosis. Clinical Radiology 2011; 66: 708–14. doi: 10.1016/j.crad.2011.03.002
- Shin SY, Kim MY, Oh SY, Lee HJ, Hong SA, Jang SJ, et al. Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center. Medicine (Baltimore) 2015; 94: 1–10. doi: 10.1097/MD.0000000000000498
- Trabucco SMR, Brascia D, Cazzato G, De Iaco G, Colagrande A, Signore F, et al. Pulmonary sclerosing pneumocytoma: a pre and intraoperative diagnostic challenge. Report of two cases and review of the literature. Medicina (Kaunas) 2021; 57: 524. doi: 10.3390/medicina57060524
- Bae K, Song DH, Jeon KN, Kim SH. Pulmonary sclerosing pneumocytoma presenting a peritumoral halo and an intervening lucent zone on computed tomography: radiology-pathology correlation. Thorac Cancer 2019; 10: 1295–6. doi: 10.1111/1759-7714.13069